[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100577562":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":52,"collaborators":26,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":56,"sex":61,"minAge":62,"maxAge":26,"enrollmentInfo":63,"targetDuration":26,"studyType":66,"phases":67,"briefSummary":69,"conditions":70,"keywords":78,"overallStatus":39,"whyStopped":26,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":93},{"fullName":5,"class":6},"Centre Hospitalier Universitaire, Amiens","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Free UF Prescription","ACTIVE_COMPARATOR","Free UF Prescription :\n\nThe UF (ml\u002Fh) is prescribed by the responsible physician based on the patient's clinical, congestive, and hemodynamic status. The physician can implement the UF whenever necessary based on the patient's hemodynamic condition.",[13],"Procedure: continuous renal replacement therapy (CRRT)",{"label":15,"type":16,"description":17,"interventionNames":18},"UF Prescription Guided by the ECW\u002FTBWat Ratio","EXPERIMENTAL","Experimental Group - UF Prescription Guided by the ECW\u002FTBWat Ratio :\n\n* In the experimental group, the patient will receive a prescription for UF guided by the ECW\u002FTBWat ratio. The goal is to achieve an ECW\u002FTBWat ratio of less than 0.400 by the end of the 72-hour RRT session.\n* To meet this objective, the physician must measure the ECW\u002FTBWat ratio each time the UF is adjusted. If the patient's ECW\u002FTBWat ratio is less than 0.400 at the measurement time, the goal is to maintain it below 0.400 during the RRT session.\n* To calculate the ECW\u002FTBWATratio, the Inbody BWA 2.0 device requires the initial TBW, which will be measured by the Hill-Room Acella 900 bed (Hill-Room, Batesville, USA).\n* The ratio is calculated by the Inbody BWA 2.0 and is based on the average of 3 consecutive measurements.\n* The physician determines the prescription for adjusting the UF (ml\u002Fh) based on the patient's hemodynamic and clinical condition during the RRT session.",[19],"Other: Free UF Prescription",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","continuous renal replacement therapy (CRRT)","The patient is included in the study once they meet the eligibility criteria and as soon as the responsible physician has prescribed RRT according to the department's protocol. Randomization will be performed, and the patient will be assigned to either the standard or experimental groups.",[9],null,{"type":6,"name":9,"description":28,"armGroupLabels":29,"otherNames":26},"The UF (ml\u002Fh) is prescribed by the responsible physician based on the patient's clinical, congestive, and hemodynamic status. The physician can implement the UF whenever necessary based on the patient's hemodynamic condition.",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Christophe Beyls, MD","CONTACT","33 + 03 22 08 78 66","beyls.christophe@chu-amiens.fr",[37],{"facility":38,"status":39,"city":40,"state":26,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"CHRU Amiens","RECRUITING","Salouël","80480","France","FR",{"type":45,"coordinates":46},"Point",[47,48],2.2434,49.86988,{"lat":48,"lon":47},[51],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},{"type":53,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100577562","optimization-of-fluid-balance-guided-by-bioelectrical-impedance-analysis-in-patients-undergoing-continuous-renal-replacement-therapy-in-critical-care-100577562",false,"NCT06799910","Optimization of Fluid Balance Guided by Bioelectrical Impedance Analysis in Patients Undergoing Continuous Renal Replacement Therapy in Critical Care","OBHIMER","Inclusion Criteria:\n\n* Age \\> 18 years\n* The patient was hospitalized in the intensive care unit of Amiens-Picardie University Hospital.\n* Patient with an increase in fluid balance (TBW \\> 5%)\n* Patient receiving continuous veno-venous hemofiltration (CVVH) on a PrismaFlexR or PrisMaxR machine, initiated due to oliguria, potassium level \\> 6.5 mmol\u002FL, urea level \\> 25 mmol\u002FL, or creatinine \\> 300 µmol\u002FL and severe metabolic acidosis (pH \\\u003C 7.2).\n* Hemodynamically stable patient with a mean arterial pressure (MAP) \\> 65 mmHg for more than 4 hours with norepinephrine.\n* Signed consent to participate in the study by the patient or, if unconscious, their legal representative\u002Fnext of kin.\n\nExclusion Criteria:\n\n* Invalid BIA measurements\n* Internal device powered by an electrical current (pacemaker, implantable cardioverter-defibrillator, neurostimulator)\n* Cardiac arrhythmia (atrial fibrillation, atrial flutter) present at the inclusion\n* Chronic dialysis patient\n* Moribund patient\n* The patient is on extracorporeal mechanical support\n* Hemorrhagic shock\n* Pregnant woman\n* Patient under guardianship or conservators.","ALL","18 Years",{"count":64,"type":65},60,"ESTIMATED","INTERVENTIONAL",[68],"NA","In critical care, hemodynamic instability often requires volume expansion to restore tissue perfusion, increasing fluid balance and TBW, factors associated with higher mortality. Excess fluid leads to organ dysfunction due to venous congestion, making fluid removal crucial. When diuretics fail, RRT, typically through continuous renal replacement therapy (CRRT), is recommended. However, prescribing the correct level of UF is challenging; insufficient UF can worsen edema, while excessive UF risks hemodynamic instability. This pilot, single-center, prospective, interventional, randomized, controlled, open-label study includes two parallel groups: a standard group with UF prescribed by the physician based on clinical and hemodynamic status and an experimental group with UF guided by the extracellular to total body water (ECW\u002FTBWat) ratio measured by BIA. The aim is to determine if ECW\u002FTBW-guided UF improves fluid and TBW reduction over a 72-hour RRT period.",[71,72,73,74,75,76,77],"Congestion","RRT","UF","Bio-impendance Analysis","Fluid Removal","Diuretics","Overload",[79,80,81,82,83,72,73],"bio-impendance analysis","fluid removal","diuretics","overload","congestion","2025-01-28",{"date":86,"type":87},"2025-01-29","ACTUAL",{"date":89,"type":87},"2024-09-26",{"date":91,"type":65},"2026-06",{"name":5,"class":6},1]